Switching patterns of GLP-1 receptor agonists from 2018 to 2025 in the largest private healthcare network in Poland.

Acta Diabetol · 2026 · PMC13395827 · PMID 42142150

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

a nonsignificant trendP = 0.07so close (0.05 < p ≤ 0.1)

Dulaglutide showed a nonsignificant trend toward higher switching odds (OR, 1.70; 95% CI, 0.95–3.04; P = 0.07), whereas oral semaglutide did not differ significantly (OR, 1.30; 95% CI, 0.78–2.17; P = 0.31).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.